Users Coming Off Slimming Injections Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

New research reveals that individuals who come off blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise programs.

Published data in a prominent medical journal points out that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.

"People buying these medications need to be informed of the danger of quick rebound weight gain when the medication concludes," warns researcher Dr. Susan Jebb.

That rate of regain implies a return to starting mass within about a year and a half.

Weighing Approaches

The research, which reviewed dozens of trials involving over 9,000 of participants, contrasted the results of these new drugs with older methods.

Scientists note that people who shed pounds through diet and exercise usually experience a slower creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Doctors believe the way of the jabs accounts for the heightened weight return.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of the hormone levels several times higher than normal may cause the system to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication results in appetite is uncontrolled, making excessive eating far more likely."

A Lifelong Disease?

Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Many experts argue that, due to the likelihood of weight regain, the therapy is often life-long.

This opinion is echoed by drug manufacturers, who note that the results "highlight the long-term character of obesity," comparing it to managing diseases like high blood pressure.

User Accounts

Individuals who have come off the medication explain a powerful return of appetite.

"It was like something flipping and you're instantly starving," described an individual.

This challenge is compounded if patients have not established permanent lifestyle or habit modifications during therapy.

Significant Adoption

Figures show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.

• Use is greater among females than males.
• The middle-aged demographic shows the highest usage rates.
• A large proportion access the medications through private healthcare rather than public health services.

Ultimately, clinicians stress that while the jabs are effective tools for shedding pounds, they are not a magic cure and long-term success likely depends on ongoing behavioural changes.